JMI LABS IS NOW PART OF LEARN MORE

Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Evaluate Susceptibility Breakpoints (SB) for Labeled Cefepime Dosing Regimens, Lead author: Van Wart, presented at 50th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 12 – 15, 2010, Boston, MA